Common sense investment opportunities around the world

Weekly newsletter (free)

In-depth research reports (from USD 49 p.a.)

Expand your thinking by tapping Into my 25+ years of global investment research expertise

~|elegant-themes~|elegant-themes-icon~|

Discover world-class companies trading at low prices

~|elegant-themes~|elegant-themes-icon~|

Beat low interest rates with dividend yield strategies

~|elegant-themes~|elegant-themes-icon~|

Benefit from a different, independent view of the world

Discover my investment ideas

Curious how my in-depth research reports look like? Download a FREE sample report (PDF - 6MB)

MOST POPULAR

Free weekly dispatches

Join for free to get my weekly columns with investment insights from around the world - and my FREE eBook "The world's best investing blogs".

You can unsubscribe at any time and I'll treat your data with respect, in line with my Privacy Policy.

Name(Required)
Name(Required)
This field is for validation purposes and should be left unchanged.

Latest Reports for Members

Bayer AG: similar to buying Volkswagen two years ago?

Bayer AG: a German blue chip with 100% upside

10 September 2021

It is tremendously valuable to have a few decades of real-life experience to lean on.

Among other things, it helps you put things in perspective. You find it easier to keep a cool head when everyone else is panicking.

Case in point, the hysteria surrounding Bayer's "Roundup" trials in the US.

Admittedly, it's an awful mess:

  • Many victims and human misery.
  • EUR 23bn in one-off charges in 2020 alone.
  • EUR 74bn of shareholder value destroyed.

However, I believe: "This, too, shall pass."

Following my analysis, I expect Bayer to experience a similar recovery as the one it staged from 2003 onwards. Back then, the German life science company experienced a similar scandal – but its stock subsequently rose by a factor of 7.

Will Bayer manage to stage a turnaround yet again? 

This report believes it can, and will. Starting in 2022, and possibly as early as Q4/21.

A groundfloor opportunity in gaming and esports

A groundfloor opportunity in gaming and esports

Novavax: The

Novavax: The "best" coronavirus vaccine and an undervalued stock?

"Dollar stores" are coming to Europe

IWG cover

IWG plc: the hybrid work model stock

What members say

~|elegant-themes~|elegant-themes-icon~||

Your reports are always a joy to read and they give a solid perspective on interesting investment opportunities. Big thanks for that.

Tibor, Oman

~|elegant-themes~|elegant-themes-icon~||

This Membership is the best investment in your own stock market future. Anyone looking for an experienced opportunity finder will find what they need with Swen Lorenz!

Moritz H., Germany

~|elegant-themes~|elegant-themes-icon~||

Unrivaled value for retail investors in your reports. Gazprom actually helped me pay off one of my student loans which I've been struggling with for a while. Your work is changing lives.

Tyler, USA

~|elegant-themes~|elegant-themes-icon~||

Thanks again for all your great reports and I do already look forward to the next one!

Johannes, Hong Kong

~|elegant-themes~|elegant-themes-icon~||

Have read through all your reports and just want to thank you again for the amazing insight. Can't tell you how valuable and interesting I find them, just what I am looking for.

Steve P., Australia

~|elegant-themes~|elegant-themes-icon~||

You are the Sherlock Holmes of the stock market. Love your analysis. It's not only pretty accurate but fun to read.

Pablo, Argentina

As seen in

Most recent

Latest reports (for Members only)

Bayer AG: similar to buying Volkswagen two years ago?

Bayer AG: similar to buying Volkswagen three years ago?

German blue chip Bayer is currently down and out. 2022 should bring a turnaround, though, similar to the one seen at Volkswagen.

A groundfloor opportunity in gaming and esports

A groundfloor opportunity in gaming and esports

This European entertainment champion is looking to turn itself into a global giant - and could gain 125% by mid-2022.

Novavax: The "best" coronavirus vaccine and an undervalued stock?

Novavax: The "best" coronavirus vaccine and an undervalued stock?

Can coronavirus vaccine maker Novavax profit from the vast majority of unvaccinated people, and make vaccine sceptics fall in love with it?